217 related articles for article (PubMed ID: 34347308)
1. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.
González Rodríguez C; Fuentes Cantero S; Pérez Pérez A; Vázquez Barbero FJ; León Justel A
J Clin Lab Anal; 2021 Sep; 35(9):e23914. PubMed ID: 34347308
[TBL] [Abstract][Full Text] [Related]
2. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antinuclear antibody profiles obtained using line immunoassay and fluorescence enzyme immunoassay.
Jang J; Kim S; Kim HS; Lee KA; Park J; Park Y
J Int Med Res; 2021 Jun; 49(6):3000605211014390. PubMed ID: 34154430
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an Automated Screening Assay, Compared to Indirect Immunofluorescence, an Extractable Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinuclear Antibody-Associated Rheumatoid Diseases: A Multicenter Retrospective Study.
Jeong S; Hwang H; Roh J; Shim JE; Kim J; Kim GT; Tag HS; Kim HS
J Immunol Res; 2018; 2018():9094217. PubMed ID: 29854849
[TBL] [Abstract][Full Text] [Related]
5. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort.
Miyara M; Albesa R; Charuel JL; El Amri M; Fritzler MJ; Ghillani-Dalbin P; Amoura Z; Musset L; Mahler M
Clin Dev Immunol; 2013; 2013():703759. PubMed ID: 23476678
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
7. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
[TBL] [Abstract][Full Text] [Related]
8. Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases.
Yuan W; Cao H; Li W; Wu X; Zheng J
Clin Rheumatol; 2022 Mar; 41(3):899-909. PubMed ID: 34626262
[TBL] [Abstract][Full Text] [Related]
9. The clinical relevance of anti-dsDNA antibodies determined by the Elia™ dsDNA assay in patients with negative indirect immunofluorescence on the HEp-2 cell.
Robier C; Haas M; Quehenberger F
Clin Chem Lab Med; 2021 Feb; 59(3):541-546. PubMed ID: 33064668
[TBL] [Abstract][Full Text] [Related]
10. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases.
Bizzaro N; Brusca I; Previtali G; Alessio MG; Daves M; Platzgummer S; Cinquanta L; Paura G; Infantino M; Manfredi M; Faricelli R; Bassetti D; Musso M; Deleonardi G; Trevisan MT; Radice A; Liguori M; Imbastaro T; Pesente F; Fabris M; Tonutti E
Autoimmun Rev; 2018 Jun; 17(6):541-547. PubMed ID: 29631063
[No Abstract] [Full Text] [Related]
11. Clinical Performance of Two Automated Immunoassays, EliA CTD Screen and QUANTA Flash CTD Screen Plus, for Antinuclear Antibody Screening.
Yoon S; Moon HW; Kim H; Hur M; Yun YM
Ann Lab Med; 2022 Jan; 42(1):63-70. PubMed ID: 34374350
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ANA testing by indirect immunofluorescence or solid-phase assays in a low pre-test probability population for systemic autoimmune disease: the Camargo Cohort.
Martinez-Revuelta D; Irure-Ventura J; López-Hoyos M; Olmos JM; Pariente E; Martín-Millán M; Nan D; Comins-Boo A; Martínez-Taboada VM; Hernández JL
Clin Chem Lab Med; 2023 May; 61(6):1095-1104. PubMed ID: 36634098
[TBL] [Abstract][Full Text] [Related]
13. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
14. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
15. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases.
Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J
J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841
[TBL] [Abstract][Full Text] [Related]
16. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
Sener AG; Afsar I; Demirci M
APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
[TBL] [Abstract][Full Text] [Related]
18. Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.
Claessens J; Belmondo T; De Langhe E; Westhovens R; Poesen K; Hüe S; Blockmans D; Mahler M; Fritzler MJ; Bossuyt X
Autoimmun Rev; 2018 Jun; 17(6):533-540. PubMed ID: 29526634
[TBL] [Abstract][Full Text] [Related]
19. Low positive rate of serum autoantibodies in colorectal cancer patients without systemic rheumatic diseases.
Fernández-Suárez A; Muñoz-Colmenero A; Ocaña-Pérez E; Fatela-Cantillo D; Domínguez-Jiménez JL; Díaz-Iglesias JM
Autoimmunity; 2016 Sep; 49(6):383-387. PubMed ID: 27424781
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of screening methods for the determination of antinuclear antibodies using indirect immunofluorescence on HEp-2 cells and enzyme immunoassay in autoimmune liver diseases.
Dorofeev AS; Aleksandrova EN; Novikov AA; Saliev KG; Sandler YG; Vinnitskaya EV
Klin Lab Diagn; 2022 Nov; 67(11):652-657. PubMed ID: 36398774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
